Magnetic resonance and PET studies in the early diagnosis of Alzheimer’s disease

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915 · see citing works

Neuropathological stageing of Alzheimer-related changes.

Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · see citing works

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics

Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · see citing works

Statistical parametric maps in functional imaging: A general linear approach

Friston, K. J., Holmes, A. P., Worsley, K. J., Poline, J. ‐., Frith, C. D., & Frackowiak, R. S. J. (1994) · Human Brain Mapping · doi:10.1002/hbm.460020402 · Cited by 9,688 · see citing works

Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families

Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429 · see citing works

Mild Cognitive Impairment: Clinical Characterization and Outcome

Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980 · see citing works

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496 · see citing works

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R., Hansen, L. A., & Katzman, R. (1991) · Annals of Neurology · doi:10.1002/ana.410300410 · Cited by 4,397 · see citing works

Alzheimer's disease: cell-specific pathology isolates the hippocampal formation.

Hyman, B. T., Van Hoesen, G. W., Damasio, A. R., & Barnes, C. L. (1984) · Science · doi:10.1126/science.6474172 · Cited by 2,268 · see citing works

Hippocampal atrophy in recurrent major depression

Sheline, Y. I., Wang, P. W., Gado, M. H., Csernansky, J. G., & Vannier, M. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3908 · Cited by 1,932 · see citing works

Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease

Minoshima, S., Giordani, B., Berent, S., Frey, K. A., Foster, N. L., & Kuhl, D. E. (1997) · Annals of Neurology · doi:10.1002/ana.410420114 · Cited by 1,802 · see citing works

Profound Loss of Layer II Entorhinal Cortex Neurons Occurs in Very Mild Alzheimer’s Disease

Gómez-Isla, T., Price, J. L., McKeel Jr., D. W., Morris, J. C., Growdon, J. H., & Hyman, B. T. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-14-04491.1996 · Cited by 1,796 · see citing works

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

Brookmeyer, R., Gray, S. G., & Kawas, C. H. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,774 · see citing works

Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment

Jack, C. R., Petersen, R. C., Xu, Y. C., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Waring, S. C., Tangalos, E. G., & Kokmen, E. (1999) · Neurology · doi:10.1212/wnl.52.7.1397 · Cited by 1,404 · see citing works

Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's disease

DeMattos, R. B., Bales, K. R., Cummins, D. J., Dodart, J.-C., Paul, S. M., & Holtzman, D. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151261398 · Cited by 1,298 · see citing works

CSF markers for incipient Alzheimer's disease

Blennow, K., & Hampel, H. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00530-1 · Cited by 1,291 · see citing works

Correlation Between Elevated Levels of Amyloid β-Peptide in the Brain and Cognitive Decline

Näslund, J. (2000) · JAMA · doi:10.1001/jama.283.12.1571 · Cited by 1,268 · see citing works

Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease

Jack, C. R., Petersen, R. C., Xu, Y. C., Waring, S. C., O'Brien, P. C., Tangalos, E. G., Smith, G. E., Ivnik, R. J., & Kokmen, E. (1997) · Neurology · doi:10.1212/wnl.49.3.786 · Cited by 1,128 · see citing works

A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET.

(1995) · PubMed Central · doi:10.2967/jnumed.120.252510a · Cited by 996 · see citing works

Positron Emission Tomography in Evaluation of Dementia

Silverman, D. H. S., Small, G. W., Chang, C. Y., Lu, C. S., de Aburto, M. A. K., Chen, W., Czernin, J. G., Rapoport, S. I., Pietrini, P., Alexander, G. E., et al. (2001) · JAMA · doi:10.1001/jama.286.17.2120 · Cited by 939 · see citing works

Rates of hippocampal atrophy correlate with change in clinical status in aging and AD

Jack, C. R., Petersen, R. C., Xu, Y., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Boeve, B. F., Tangalos, E. G., & Kokmen, E. (2000) · Neurology · doi:10.1212/wnl.55.4.484 · Cited by 937 · see citing works

Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PET

Herholz, K., Salmon, E., Perani, D., Baron, J.-C., Holthoff, V., Frölich, L., Schönknecht, P., Ito, K., Mielke, R., & Kalbe, E. (2002) · NeuroImage · doi:10.1006/nimg.2002.1208 · Cited by 832 · see citing works

Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD

Jack, C. R., Shiung, M. M., Gunter, J. L., O’Brien, P. C., Weigand, S. D., Knopman, D. S., Boeve, B. F., Ivnik, R. J., Smith, G. E., Cha, R. H., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000110315.26026.ef · Cited by 827 · see citing works

The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease

Price, J. L., Davis, P. B., Morris, J. C., & White, D. L. (1991) · Neurobiology of Aging · doi:10.1016/0197-4580(91)90006-6 · Cited by 818 · see citing works

Cerebral metabolic and cognitive decline in persons at genetic risk for Alzheimer’s disease

Small, G. W., Ercoli, L. M., Silverman, D. H. S., Huang, S.-C., Komo, S., Bookheimer, S. Y., Lavretsky, H., Miller, K., Siddarth, P., Rasgon, N. L., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090106797 · Cited by 790 · see citing works

Improved discrimination of AD patients using β-amyloid _(1-42) and tau levels in CSF

Hulstaert, F., Blennow, K., Ivanoiu, A., Schoonderwaldt, H. C., Riemenschneider, M., Deyn, P. P. D., Bancher, C., Cras, P., Wiltfang, J., Mehta, P. D., et al. (1999) · Neurology · doi:10.1212/wnl.52.8.1555 · Cited by 724 · see citing works

REGIONAL CEREBRAL OXYGEN SUPPLY AND UTILIZATION IN DEMENTIA: A CLINICAL AND PHYSIOLOGICAL STUDY WITH OXYGEN-15 AND POSITRON TOMOGRAPHY A CLINICAL AND PHYSIOLOGICAL STUDY WITH OXYGEN - 15 AND POSITRON TOMOHRAPHY

Frackowiak, R. S. J., Pozzilli, C., Legg, N. J., du Boulay, G. H., MARSHALL, J., Lenzi, G. L., & Jones, T. (1981) · Brain · doi:10.1093/brain/104.4.753 · Cited by 685 · see citing works

Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease

Killiany, R., Gómez‐Isla, T., Moss, M. B., Kikinis, R., Sándor, T., Jolesz, F. A., Tanzi, R. E., Jones, K. J., Hyman, B. T., & Albert, M. (2000) · Annals of Neurology · doi:10.1002/1531-8249(200004)47:4 · Cited by 659 · see citing works

Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer’s disease

Arriagada, P. V., Marzloff, K., & Hyman, B. T. (1992) · Neurology · doi:10.1212/wnl.42.9.1681 · Cited by 638 · see citing works

Prediction of cognitive decline in normal elderly subjects with 2-[ ¹⁸ F]fluoro-2-deoxy- <scp>d</scp> -glucose/positron-emission tomography (FDG/PET)

de Leon, M. J., Convit, A., Wolf, O. T., Tarshish, C. Y., DeSanti, S., Rusinek, H., Tsui, W., Kandil, E., Scherer, A. J., Roche, A., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191044198 · Cited by 629 · see citing works

Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia

Jack, C. R., Dickson, D. W., Parisi, J. E., Xu, Y. C., Cha, R. H., O’Brien, P. C., Edland, S. D., Smith, G. E., Boeve, B. F., Tangalos, E. G., et al. (2002) · Neurology · doi:10.1212/wnl.58.5.750 · Cited by 610 · see citing works

Mild cognitive impairment

Chételat, G., Desgranges, B., Sayette, V. D. L., Viader, F., Eustache, F., & Baron, J. (2003) · Neurology · doi:10.1212/01.wnl.0000055847.17752.e6 · Cited by 604 · see citing works

Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study

Siebner, H. R., Riemenschneider, M. J., Willoch, F., Minoshima, S., Schwaiger, M., Kurz, A., Drzezga, A. E., & Lautenschlager, N. T. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-003-1194-1 · Cited by 603 · see citing works

Neuron Number in the Entorhinal Cortex and CA1 in Preclinical Alzheimer Disease

Price, J. L., Ko, A. I., Wade, M. J., Tsou, S. K., McKeel, D. W., & Morris, J. C. (2001) · Archives of Neurology · doi:10.1001/archneur.58.9.1395 · Cited by 596 · see citing works

Plasma and Cerebrospinal Fluid Levels of Amyloid β Proteins 1-40 and 1-42 in Alzheimer Disease

Mehta, P. D., Pirttilä, T., Mehta, S. P., Sersen, E. A., Aisen, P. S., & Wisniewski, H. M. (2000) · Archives of Neurology · doi:10.1001/archneur.57.1.100 · Cited by 582 · see citing works

Evaluation of CSF-tau and CSF-Aβ42 as diagnostic markers for Alzheimer disease in clinical practice

Andreasen, N., Minthon, L., Davidsson, P., Vanmechelen, E., Vanderstichele, H., Winblad, B., & Blennow, K. (2001) · Archives of Neurology · doi:10.1001/archneur.58.3.373 · Cited by 573 · see citing works

Neurofibrillary Tangles, Amyloid, and Memory in Aging and Mild Cognitive Impairment

Guillozet-Bongaarts, A. L., Weıntraub, S., Mash, D. C., & Mesulam, M. M. (2003) · Archives of Neurology · doi:10.1001/archneur.60.5.729 · Cited by 572 · see citing works

MRI measures of entorhinal cortex vs hippocampus in preclinical AD

Killiany, R., Hyman, B. T., Gómez‐Isla, T., Moss, M. B., Kikinis, R., Jolesz, F. A., Tanzi, R. E., Jones, K., & Albert, M. (2002) · Neurology · doi:10.1212/wnl.58.8.1188 · Cited by 564 · see citing works

Alzheimer's disease versus dementia with Lewy bodies: Cerebral metabolic distinction with autopsy confirmation

Minoshima, S., Foster, N. L., Sima, A. A. F., Frey, K. A., Albin, R. L., & Kuhl, D. E. (2001) · Annals of Neurology · doi:10.1002/ana.1133 · Cited by 560 · see citing works

Hippocampal formation glucose metabolism and volume losses in MCI and AD

De Santi, S., de Leon, M. J., Rusinek, H., Convit, A., Tarshish, C. Y., Roche, A., Tsui, W. H., Kandil, E., Boppana, M., Daisley, K., et al. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00230-5 · Cited by 548 · see citing works

Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid: a sandwich ELISA with a synthetic phosphopeptide for standardization

Vanmechelen, E., Vanderstichele, H., Davidsson, P., Kerschaver, E. V., Perre, B. V. D., Sjögren, M. J. C., Andreasen, N. C., & Blennow, K. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)01036-3 · Cited by 487 · see citing works

MRI-derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer’s disease ☆ ☆This research was supported by grants P01 AG09466 and P30 AG10161 from the National Institute on Aging, National Institutes of Health.

Dickerson, B. C., Goncharova, I. I., Sullivan, M., Forchetti, C., Wilson, R. S., Bennett, D. A., Beckett, L. A., & deToledo‐Morrell, L. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00271-8 · Cited by 481 · see citing works

Very mild Alzheimer's disease: Informant‐based clinical, psychometric, and pathologic distinction from normal aging

Morris, J. C., McKeel, D. W., Storandt, M., Rubin, E. H., Price, J. L., Grant, E. A., Ball, M. J., & Berg, L. (1991) · Neurology · doi:10.1212/wnl.41.4.469 · Cited by 473 · see citing works

Preclinical prediction of Alzheimer's disease using SPECT

Johnson, K. A., Jones, K., Holman, B. L., Becker, J. A., Spiers, P. A., Satlin, A., & Albert, M. S. (1998) · Neurology · doi:10.1212/wnl.50.6.1563 · Cited by 471 · see citing works

Declining brain activity in cognitively normal apolipoprotein E ɛ4 heterozygotes: A foundation for using positron emission tomography to efficiently test treatments to prevent Alzheimer's disease

Reiman, E. M., Caselli, R. J., Chen, K., Alexander, G. E., Bandy, D., & Frost, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061509598 · Cited by 467 · see citing works

The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease

Bobinski, M., de Leon, M. J., Wegiel, J., DeSanti, S., Convit, A., Saint Louis, L. A., Rusinek, H., & Wisniewski✠, H. M. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00476-5 · Cited by 455 · see citing works

Neuroplasticity Failure in Alzheimer's Disease

Mesulam, M.-M. (1999) · Neuron · doi:10.1016/s0896-6273(00)81109-5 · Cited by 449 · see citing works

High Cerebrospinal Fluid Tau and Low Amyloid β42 Levels in the Clinical Diagnosis of Alzheimer Disease and Relation to Apolipoprotein E Genotype

Galasko, D., Chang, L., Motter, R., Clark, C. M., Kaye, J., Knopman, D., Thomas, R., Kholodenko, D., Schenk, D., Lieberburg, I., et al. (1998) · Archives of Neurology · doi:10.1001/archneur.55.7.937 · Cited by 442 · see citing works

Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease

De Leon, M. J., George, A. E., Golomb, J., Tarshish, C., Convit, A., Kluger, A., De Santi, S., Mc Rae, T., Ferris, S. H., Reisberg, B., et al. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(96)00213-8 · Cited by 429 · see citing works

A NEW DEFINITION OF ALZHEIMER'S DISEASE: A HIPPOCAMPAL DEMENTIA

Ball, M. J., Hachinski, V., Fox, A. J., Kirshen, A. J., Fisman, M., Blume, W. T., Kral, V. A., Fox, H., & Merskey, H. (1985) · The Lancet · doi:10.1016/s0140-6736(85)90965-1 · Cited by 427 · see citing works

Specific Hippocampal Volume Reductions in Individuals at Risk for Alzheimer’s Disease

Convit, A., De Leon, M. J., Tarshish, C., De Santi, S., Tsui, W., Rusinek, H., & George, A. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00001-8 · Cited by 427 · see citing works

Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment

Nestor, P. J., Fryer, T. D., Smielewski, P. S., & Hodges, J. R. (2003) · Annals of Neurology · doi:10.1002/ana.10669 · Cited by 414 · see citing works

Automatic Differentiation of Anatomical Patterns in the Human Brain: Validation with Studies of Degenerative Dementias

Good, C. D., Scahill, R. I., Fox, N. C., Ashburner, J., Friston, K. J., Chan, D., Crum, W. R., Rossor, M. N., & Frackowiak, R. S. J. (2002) · NeuroImage · doi:10.1006/nimg.2002.1202 · Cited by 410 · see citing works

Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia

Kaye, J. A., Swihart, T., Howieson, D., Dame, A., Moore, M. M., Karnos, T., Camicioli, R., Ball, M., Oken, B., & Sexton, G. (1997) · Neurology · doi:10.1212/wnl.48.5.1297 · Cited by 399 · see citing works

Visualisation and quantification of rates of atrophy in Alzheimer's disease

Fox, N. C., Freeborough, P. A., & Rossor, M. N. (1996) · The Lancet · doi:10.1016/s0140-6736(96)05228-2 · Cited by 378 · see citing works

Cortical abnormalities in Alzheimer's disease

Foster, N. L., Chase, T. N., Mansi, L., Brooks, R., Fedio, P., Patronas, N. J., & Chiro, G. D. (1984) · Annals of Neurology · doi:10.1002/ana.410160605 · Cited by 378 · see citing works

Temporal Lobe Regions on Magnetic Resonance Imaging Identify Patients With Early Alzheimer's Disease

Killiany, R., Moss, M. B., Albert, M., Sándor, T., Tieman, J., & Jolesz, F. A. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540090052010 · Cited by 371 · see citing works

Longitudinal evaluation of early Alzheimer's disease using brain perfusion SPECT.

Kogure, D., Matsuda, H., Ohnishi, T., Asada, T., Uno, M., Kunihiro, T., Nakano, S., & Takasaki, M. (2000) · PubMed · Cited by 367 · see citing works

Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predict decline to Alzheimer’s disease☆

Convit, A., de Asis, J., de Leon, M. J., Tarshish, C. Y., De Santi, S., & Rusinek, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(99)00107-4 · Cited by 359 · see citing works

Myocardial Disorders in the Elderly

Brown, J. J., DAVIES, D. L., Lever, A., PARKER, R. A., & ROBERTSON, J. I. (1963) · The Lancet · doi:10.1016/s0140-6736(63)90462-8 · Cited by 348 · see citing works

The neural substrates of memory systems impairment in Alzheimer's disease. A PET study of resting brain glucose utilization

Desgranges, B. (1998) · Brain · doi:10.1093/brain/121.4.611 · Cited by 326 · see citing works

Regional glucose metabolic abnormalities are not the result of atrophy in Alzheimer's disease

Ibáñez, V., Pietrini, P., Alexander, G. E., Furey, M. L., Teichberg, D., Rajapakse, J. C., Рапопорт, С. И., Schapiro, M. B., & Horwitz, B. (1998) · Neurology · doi:10.1212/wnl.50.6.1585 · Cited by 322 · see citing works

The radiologic prediction of Alzheimer disease: the atrophic hippocampal formation.

de Leon, M. J., Golomb, J. B., GEORGE, A. E., Convit, A. J., Tarshish, C. Y., McRae, T., Santi, S. D., Smith, G. S., Ferris, S. H., & Noz, M. E. (1993) · PubMed Central · Cited by 322 · see citing works

Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment

Visser, P. J., Scheltens, P., Verhey, F. R. J., Schmand, B., Launer, L. J., Jolles, J., & Jonker, C. (1999) · Journal of Neurology · doi:10.1007/s004150050387 · Cited by 319 · see citing works

Neuropathological and Neuropsychological Changes in “Normal” Aging: Evidence for Preclinical Alzheimer Disease in Cognitively Normal Individuals

HULETTE, C. M., WELSH-BOHMER, K. A., MURRAY, M. G., SAUNDERS, A. M., MASH, D. C., & MCINTYRE, L. M. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199812000-00009 · Cited by 311 · see citing works

Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment

Arnáiz, E., Jelic, V., Almkvist, O., Wahlund, L.-O., Winblad, B., Valind, S., & Nordberg, A. (2001) · Neuroreport · doi:10.1097/00001756-200103260-00045 · Cited by 302 · see citing works

Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease

Haroutunian, V. (1998) · Archives of Neurology · doi:10.1001/archneur.55.9.1185 · Cited by 289 · see citing works

EARLY MARKER FOR ALZHEIMER'S DISEASE: THE ATROPHIC HIPPOCAMPUS

De Leon, M., George, A., Stylopoulos, L., Smith, G., & Miller, D. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90911-2 · Cited by 284 · see citing works

Differentiating frontal and temporal variant frontotemporal dementia from Alzheimer’s disease

Perry, R. J., & Hodges, J. R. (2000) · Neurology · doi:10.1212/wnl.54.12.2277 · Cited by 281 · see citing works

Regional Brain Atrophy Rate Predicts Future Cognitive Decline: 6-year Longitudinal MR Imaging Study of Normal Aging

Rusinek, H., De Santi, S., Frid, D., Tsui, W.-H., Tarshish, C. Y., Convit, A., & de Leon, M. J. (2003) · Radiology · doi:10.1148/radiol.2293021299 · Cited by 281 · see citing works

Differential Diagnosis of Alzheimer Disease With Cerebrospinal Fluid Levels of Tau Protein Phosphorylated at Threonine 231

Büerger, K., Zinkowski, R. P., Teipel, S. J., Tapiola, T., Arai, H., Blennow, K., Andreasen, N., Hofmann‐Kiefer, K., DeBernardis, J. F., Kerkman, D. J., et al. (2002) · Archives of Neurology · doi:10.1001/archneur.59.8.1267 · Cited by 275 · see citing works

Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease

Reiman, E. M., Uecker, A., Caselli, R. J., Lewis, S., Bandy, D., De Leon, M. J., De Santi, S., Convit, A., Osborne, D., Weaver, A., et al. (1998) · Annals of Neurology · doi:10.1002/ana.410440226 · Cited by 266 · see citing works

MRI volumetric study of dementia with Lewy bodies

Barber, R., Ballard, C. G., McKeith, I. G., Gholkar, A. R., & O'Brien, J. T. (2000) · Neurology · doi:10.1212/wnl.54.6.1304 · Cited by 266 · see citing works

Volumes of the Entorhinal and Perirhinal Cortices in Alzheimer’s Disease

Juottonen, K., Laakso, M. P., Insausti, R., Lehtovirta, M., Pitkänen, A., Partanen, K. P. L., & Soininen, H. S. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00007-4 · Cited by 262 · see citing works

CSF tau protein phosphorylated at threonine 231 correlates with cognitive decline in MCI subjects

Büerger, K., Teipel, S. J., Zinkowski, R. P., Blennow, K., Arai, H., Engel, R. R., Hofmann‐Kiefer, K., McCulloch, C., Ptok, U., Heun, R., et al. (2002) · Neurology · doi:10.1212/wnl.59.4.627 · Cited by 255 · see citing works

Fluoro-deoxyglucose positron emission tomography in diffuse Lewy body disease

Albin, R. L., Minoshima, S., D’Amato, C. J., Frey, K. A., Kuhl, D. A., & Sima, A. A. F. (1996) · Neurology · doi:10.1212/wnl.47.2.462 · Cited by 239 · see citing works

MRI of entorhinal cortex in mild Alzheimer's disease

Bobinski, M., de Leon, M. J., Convit, A. J., Santi, S. D., Węgiel, J., Tarshish, C. Y., Louis, L. A. S., & Wı́sniewski, H. M. (1999) · The Lancet · doi:10.1016/s0140-6736(05)74869-8 · Cited by 238 · see citing works

Cerebrospinal fluid tau and Aβ42 as predictors of development of Alzheimer's disease in patients with mild cognitive impairment

Andreasen, N. C., Minthon, L., Vanmechelen, E., Vanderstichele, H., Davidsson, P., Winblad, B. G., & Blennow, K. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00617-5 · Cited by 236 · see citing works

Brain 18F-FDG PET in the diagnosis of neurodegenerative dementias: comparison with perfusion SPECT and with clinical evaluations lacking nuclear imaging.

Silverman, D. H. S. (2004) · PubMed · Cited by 236 · see citing works

Rates of global and regional cerebral atrophy in AD and frontotemporal dementia

Chan, D., Fox, N. C., Jenkins, R., Scahill, R. I., Crum, W. R., & Rossor, M. N. (2001) · Neurology · doi:10.1212/wnl.57.10.1756 · Cited by 220 · see citing works

PET studies in dementia

Herholz, K. (2003) · Annals of Nuclear Medicine · doi:10.1007/bf02988444 · Cited by 217 · see citing works

Memory impairments associated with hippocampal versus parahippocampal-gyrus atrophy: an MR volumetry study in Alzheimer’s disease

Köhler, S., Black, S. E., Sinden, M., Szekely, C. A., Kidron, D., Parker, J. L., Foster, J. K., Moscovitch, M., Wincour, G., Szalai, J. P., et al. (1998) · Neuropsychologia · doi:10.1016/s0028-3932(98)00017-7 · Cited by 216 · see citing works

Progressive brain atrophy on serial MRI in dementia with Lewy bodies, AD, and vascular dementia

O’Brien, J. T., Paling, S., Barber, R., Williams, E. D., Ballard, C., McKeith, I. G., Gholkar, A., Crum, W. R., Rossor, M. N., & Fox, N. C. (2001) · Neurology · doi:10.1212/wnl.56.10.1386 · Cited by 215 · see citing works

Patterns of Cerebral Atrophy in Dementia with Lewy Bodies Using Voxel-Based Morphometry

Burton, E. J., Karas, G. B., Paling, S. M., Barber, R., Williams, E. D., Ballard, C. G., McKeith, I. G., Scheltens, P., Barkhof, F., & O'Brien, J. T. (2002) · NeuroImage · doi:10.1006/nimg.2002.1197 · Cited by 214 · see citing works

Untitled work

(1998) · PubMed · Cited by 213 · see citing works

Imaging the progression of Alzheimer pathology through the brain

Smith, A. D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082107399 · Cited by 202 · see citing works

Positron Emission Tomography in the Study of Aging and Senile Dementia

Ferris, S. H., de Leon, M. J., Wolf, A. P., Farkas, T., Christman, D. R., Reisberg, ‌., Fowler, J. S., MacGregor, R. R., Goldman, A. G., GEORGE, A. E., et al. (1980) · Neurobiology of Aging · doi:10.1016/0197-4580(80)90005-6 · Cited by 198 · see citing works

Neuron loss from the hippocampus of Alzheimer's disease exceeds extracellular neurofibrillary tangle formation

Kril, J., Patel, S., Harding, A., & Halliday, G. (2002) · Acta Neuropathologica · doi:10.1007/s00401-001-0477-5 · Cited by 190 · see citing works

Temporal lobe rating scale: application to Alzheimer's disease and frontotemporal dementia

Galton, C. J. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.70.2.165 · Cited by 187 · see citing works

Regional hypometabolism in Alzheimer's disease as measured by positron emission tomography after correction for effects of partial volume averaging

Meltzer, C. C., Zubieta, J.-K., Brandt, J., Tune, L. E., Mayberg, H., & Frost, J. J. (1996) · Neurology · doi:10.1212/wnl.47.2.454 · Cited by 182 · see citing works

Levels of Nonphosphorylated and Phosphorylated Tau in Cerebrospinal Fluid of Alzheimer's Disease Patients

Hu, Y., He, S., Wang, X., Duan, Q., Grundke, I., Iqbal, K., & Wang, J. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62554-0 · Cited by 180 · see citing works

In vitro detection of (S)-naproxen and ibuprofen binding to plaques in the Alzheimer’s brain using the positron emission tomography molecular imaging probe 2-(1-{6-[(2-[18F]fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malononitrile

Agdeppa, E. D., Kepe, V., Petri, A., Satyamurthy, N., Liu, J., Huang, S. C., Small, G. W., Cole, G. M., & Barrio, J. R. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00907-7 · Cited by 172 · see citing works

APOE-ε4 is associated with less frontal and more medial temporal lobe atrophy in AD

Geroldi, C., Pihlajamaki, M. M., Laakso, M. P., DeCarli, C. S., Beltramello, A., Bianchetti, A., Soininen, H. S., Trabucchi, M., & Frisoni, G. B. (1999) · Neurology · doi:10.1212/wnl.53.8.1825 · Cited by 155 · see citing works

FENESTRATED TRACHEOSTOMY TUBES

LANGE, M. (1973) · The Lancet · doi:10.1016/s0140-6736(73)90918-5 · Cited by 153 · see citing works

PATHOLOGICAL AND POSITRON EMISSION TOMOGRAPHIC CORRELATIONS IN ALZHEIMER'S DISEASE

Friedland, R. P., Brun, A. E., & Budinger, T. F. (1985) · The Lancet · doi:10.1016/s0140-6736(85)92074-4 · Cited by 142 · see citing works

Neurofibrillary Pathology—Correlation With Hippocampal Formation Atrophy in Alzheimer Disease

Bobinski, M., Węgiel, J., Wı́sniewski, H. M., Tarnawski, M. J., Bobinski, M., Reisberg, ‌., de Leon, M. J., & Miller, D. C. (1996) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)85095-6 · Cited by 138 · see citing works

Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia

Varma, A. R., Adams, W., Lloyd, J. J., Carson, K. J., Snowden, J. S., Testa, H. J., Jackson, A., & Neary, D. (2002) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2002.1o148.x · Cited by 134 · see citing works

Impairment of Neocortical Metabolism Predicts Progression in Alzheimer’s Disease

Herholz, K., Nordberg, A. K., Salmon, É., Perani, D., Kessler, J., Mielke, R., Halber, M., Jelić, V., Almkvist, O., Collette, F., et al. (1999) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017196 · Cited by 129 · see citing works

Quantitative magnetic resonance imaging in geriatric depression and primary degenerative dementia

Pantel, J., Schröder, J., Essig, M., Popp, D., Dech, H., Knopp, M. V., Schad, L. R., Eysenbach, K., Backenstraβ, M., & Friedlinger, M. (1997) · Journal of Affective Disorders · doi:10.1016/s0165-0327(96)00105-x · Cited by 124 · see citing works

CSF Phosphorylated Tau Protein and Mild Cognitive Impairment: A Prospective Study

Arai, H., Ishiguro, K., Ohno, H., Moriyama, M., Itoh, N., Okamura, N., Matsui, T., Morikawa, Y.-I., Horikawa, E., Kohno, H., et al. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7501 · Cited by 123 · see citing works

Three-year follow-up of cerebrospinal fluid tau, β-amyloid 42 and 40 concentrations in Alzheimer's disease

Tapiola, T., Pirttilä, T., Mikkonen, M., Mehta, P. D., Alafuzoff, I. I., Koivisto, K. J., & Soininen, H. (2000) · Neuroscience Letters · doi:10.1016/s0304-3940(00)00767-9 · Cited by 122 · see citing works

Frontotemporal dementia and Alzheimer's disease: retrospective differentiation using information from informants.

Barber, R. C., Snowden, J. S., & Craufurd, D. (1995) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.59.1.61 · Cited by 117 · see citing works

Atrophy of the putamen in dementia with Lewy bodies but not Alzheimer’s disease

Cousins, D. A., Burton, E. J., Burn, D. J., Gholkar, A. R., McKeith, I. G., & O'Brien, J. T. (2003) · Neurology · doi:10.1212/01.wnl.0000091889.20347.30 · Cited by 112 · see citing works

The neuropathological changes associated with normal brain aging.

Hof, P. R., Glannakopoulos, P., & Bouras, C. (1996) · PubMed · Cited by 106 · see citing works

Cinguloparietal Atrophy Distinguishes Alzheimer Disease From Semantic Dementia

Boxer, A. L., Rankin, K. P., Miller, B. L., Schuff, N. W., Weiner, M. W., Gorno-Tempini, M.-L., & Rosen, H. J. (2003) · Archives of Neurology · doi:10.1001/archneur.60.7.949 · Cited by 105 · see citing works

Regional Correction of Positron Emission Tomography Data for the Effects of Cerebral Atrophy

Videen, T. O., Perlmutter, J. S., Mintun, M. A., & Raichle, M. E. (1988) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1988.113 · Cited by 98 · see citing works

Assessment of low-flow CSF drainage as a treatment for AD

Silverberg, G. D., Levinthal, E. C., Sullivan, E. V., Bloch, D. A., Chang, S. D., Leverenz, J. B., Flitman, S. S., Winn, R., Marciano, F. F., Saul, T., et al. (2002) · Neurology · doi:10.1212/01.wnl.0000031794.42077.a1 · Cited by 95 · see citing works

Longitudinal changes in lateral ventricular volume in Datients with dementia of the Alzheimer type

DeCarli, C. S., Haxby, J. V., Gillette, J., Teichberg, D., Рапопорт, С. И., & Schapiro, M. B. (1992) · Neurology · doi:10.1212/wnl.42.10.2029 · Cited by 94 · see citing works

Alzheimer’s Disease: In Vivo Detection of Differential Vulnerability of Brain Regions

deToledo‐Morrell, L., Sullivan, M., Morrell, F., Wilson, R. S., Bennett, D. A., & Spencer, S. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00114-0 · Cited by 91 · see citing works

Mapping brain size and cortical gray matter changes in elderly depression

Ballmaier, M., Sowell, E. R., Thompson, P. M., Kumar, A., Narr, K. L., Lavretsky, H., Welcome, S. E., DeLuca, H., & Toga, A. W. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.09.004 · Cited by 91 · see citing works

The effect of age and Alzheimer's disease on pyramidal neuron density in the individual fields of the hippocampal formation

Davies, D. C., Horwood, N., Isaacs, S. L., & Mann, D. M. A. (1992) · Acta Neuropathologica · doi:10.1007/bf00310028 · Cited by 88 · see citing works

MRI volumetric correlates of white matter lesions in dementia with lewy bodies and Alzheimer's disease

Barber, R., Gholkar, A. R., Scheltens, P., Ballard, C. G., McKeith, I. G., & O'Brien, J. T. (2000) · International Journal of Geriatric Psychiatry · doi:10.1002/1099-1166(200010)15:10 · Cited by 87 · see citing works

Temporal lobe magnetic resonance imaging can differentiate Alzheimer's disease from normal ageing, depression, vascular dementia and other causes of cognitive impairment

O'Brien, J. T., Desmond, P. M., Ames, D. J., Schweitzer, I., Chiu, E., & Tress, B. M. (1997) · Psychological Medicine · doi:10.1017/s0033291797005606 · Cited by 87 · see citing works

Clinical Value of Neuroimaging in the Diagnosis of Dementia Sensitivity and Specificity of Regional Cerebral Metabolic and Other Parameters for Early Identification of Alzheimer's Disease

Silverman, D. H. S. (1999) · Clinical Positron Imaging · doi:10.1016/s1095-0397(99)00020-5 · Cited by 85 · see citing works

Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease

Mosconi, L. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.014993 · Cited by 83 · see citing works

Quantitative topographical EEG compared to FDG PET for classification of vascular and degenerative dementia

Szelies, B., Mielke, R., Herholz, K., & Heiss, W. (1994) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(94)90034-5 · Cited by 65 · see citing works

A Voxel-Based Analysis of Cerebral Perfusion in Dementia and Depression of Old Age

Ebmeier, K. P., Glabus, M. F., Prentice, N. P., Ryman, A., & Goodwin, G. M. (1998) · NeuroImage · doi:10.1006/nimg.1998.0321 · Cited by 60 · see citing works

Regional correlation of PET and CT in senile dementia of the Alzheimer type.

de Leon, M. J., GEORGE, A. E., Ferris, S. H., Rosenbloom, S., Christman, D. R., Gentes, C., Reisberg, ‌., Kricheff, I. I., & Wolf, A. P. (1983) · PubMed Central · Cited by 58 · see citing works

Imaging methods for evaluating brain function in man

KESSLER, R. M. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00047-2 · Cited by 57 · see citing works

The differentiation of depression from dementia by temporal lobe magnetic resonance imaging

O'Brien, J. T., Desmond, P. M., Ames, D. J., Schweitzer, I., Tuckwell, V., & Tress, B. M. (1994) · Psychological Medicine · doi:10.1017/s0033291700027781 · Cited by 56 · see citing works

Temporal lobe abnormalities in dementia and depression: a study using high resolution single photon emission tomography and magnetic resonance imaging

Ebmeier, K. P., Prentice, N. P., Ryman, A., Halloran, E., Rimmington, J. E., Best, J. J. K., & Goodwin, G. M. (1997) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.63.5.597 · Cited by 49 · see citing works

Morphologically distinct plaque types differentially affect dendritic structure and organisation in the early and late stages of Alzheimer's disease

Adlard, P. A., & Vickers, J. C. (2002) · Acta Neuropathologica · doi:10.1007/s00401-001-0476-6 · Cited by 47 · see citing works

Amygdaloid atrophy in frontotemporal dementia and Alzheimer's disease.

Boccardi, M., Pennanen, C., Laakso, M., Testa, C., Geroldi, C., Soininen, H., & Frisoni, G. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)01169-2 · Cited by 46 · see citing works

The effect of APOE ε4 allele on cerebral glucose metabolism in AD is a function of age at onset

Hirono, N., Hashimoto, M., Yasuda, M., Ishii, K., Sakamoto, S., Kazui, H., & Mori, E. (2002) · Neurology · doi:10.1212/wnl.58.5.743 · Cited by 41 · see citing works

CORRELATIONS BETWEEN COMPUTERISED TOMOGRAPHIC CHANGES AND BEHAVIOURAL DEFICITS IN SENILE DEMENTIA

de Leon, M. J., Ferris, S. H., Blau, I., GEORGE, A. E., Reisberg, ‌., Kricheff, I. I., & Gershon, S. (1979) · The Lancet · doi:10.1016/s0140-6736(79)92217-7 · Cited by 38 · see citing works

Changes in glucose metabolism in dementia of the Alzheimer type compared with depression: A preliminary report

Guzé, B. H., Baxter, L. R., Schwartz, J. M., Szuba, M. P., Mazziotta, J. C., & Phelps, M. E. (1991) · Psychiatry Research Neuroimaging · doi:10.1016/0925-4927(91)90010-n · Cited by 36 · see citing works

Mesial Temporal Lobe Abnormalities in a Family With 15q26qter Trisomy

Kobayashi, E., Facchin, D., Steiner, C. E., LEONE, A. A. A., Viguetti‐Campos, N. L., Cendes, F., & Lopes‐Cendes, Í. (2002) · Archives of Neurology · doi:10.1001/archneur.59.9.1476 · Cited by 12 · see citing works

Dementia with Lewy bodies and AD are not associated with occipital lobe atrophy on MRI

Gerlach, M. M., Stadler, K., Aichner, F., & Ransmayr, G. N. (2002) · Neurology · doi:10.1212/wnl.59.9.1476 · Cited by 12 · see citing works

Untitled work

(1999) · doi:10.1002/1531-8249(199904)45:4

Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature

Nelson, P. T., Alafuzoff, I., Bigio, E. H., Bouras, C., Braak, H., Cairns, N. J., Castellani, R. J., Crain, B. J., Davies, P., Tredici, K. D., et al. (2012) · Journal of Neuropathology &amp; Experimental Neurology · doi:10.1097/nen.0b013e31825018f7 · Cited by 2,050 · see citing works

Brain glucose metabolism in the early and specific diagnosis of Alzheimer?s disease

Mosconi, L. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1762-7 · Cited by 900 · see citing works

Neuropathology and Cognitive Impairment in Alzheimer Disease: A Complex but Coherent Relationship

Nelson, P. T., Braak, H., & Markesbery, W. R. (2009) · Journal of Neuropathology &amp; Experimental Neurology · doi:10.1097/nen.0b013e3181919a48 · Cited by 643 · see citing works

Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial

Henderson, S. T., Vogel, J. L., Barr, L. J., Garvin, F., Jones, J. J., & Costantini, L. C. (2009) · Nutrition &amp; Metabolism · doi:10.1186/1743-7075-6-31 · Cited by 548 · see citing works

Altered neuronal gene expression in brain regions differentially affected by Alzheimer's disease: a reference data set

Liang, W. S., Dunckley, T., Beach, T. G., Grover, A., Mastroeni, D., Ramsey, K., Caselli, R. J., Kukull, W. A., McKeel, D., Morris, J. C., et al. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00242.2007 · Cited by 309 · see citing works

Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer's Disease: a cross-sectional study

Trivedi, M. A., Schmitz, T. W., Ries, M. L., Torgerson, B. M., Sager, M. A., Hermann, B. P., Asthana, S., & Johnson, S. C. (2006) · BMC Medicine · doi:10.1186/1741-7015-4-1 · Cited by 210 · see citing works

A Systematic Review of Glucose Transport Alterations in Alzheimer's Disease

Kyrtata, N., Emsley, H. C. A., Sparasci, O., Parkes, L. M., & Dickie, B. R. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.626636 · Cited by 171 · see citing works

The Influence of Alzheimer Disease Family History and Apolipoprotein E ε4 on Mesial Temporal Lobe Activation

Johnson, S. C., Schmitz, T. W., Trivedi, M. A., Ries, M. L., Torgerson, B. M., Carlsson, C. M., Asthana, S., Hermann, B. P., & Sager, M. A. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.0959-06.2006 · Cited by 149 · see citing works

Hypometabolism as a therapeutic target in Alzheimer's disease

Costantini, L. C., Barr, L. J., Vogel, J. L., & Henderson, S. T. (2008) · BMC Neuroscience · doi:10.1186/1471-2202-9-s2-s16 · Cited by 162 · see citing works

Functional Magnetic Resonance Imaging

Shah, L. M., Anderson, J. S., Lee, J. N., & Wiggins, R. H. (2010) · Seminars in Roentgenology · doi:10.1053/j.ro.2009.09.005 · Cited by 115 · see citing works

The KATP Channel Activator Diazoxide Ameliorates Amyloid-β and Tau Pathologies and Improves Memory in the 3xTgAD Mouse Model of Alzheimer's Disease

Liu, D., PITTA, M. G. R., Lee, J.-H., Ray, B., Lahiri, D. K., Furukawa, K., Mughal, M. R., Jiang, H., Villarreal, J. S., Cutler, R. G., et al. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-101017 · Cited by 113 · see citing works

Limitations of Small Animal PET Imaging with [18F]FDDNP and FDG for Quantitative Studies in a Transgenic Mouse Model of Alzheimer’s Disease

Kuntner, C., Kesner, A., Bauer, M., Kremslehner, R., Wanek, T., Mandler, M., Karch, R., Stanek, J., Wolf, T., Müller, M., et al. (2009) · Molecular Imaging and Biology · doi:10.1007/s11307-009-0198-z · Cited by 90 · see citing works

Advancements in deep learning for early diagnosis of Alzheimer’s disease using multimodal neuroimaging: challenges and future directions

Raza, M. L., Hassan, S. T., Jamil, S., Hyder, N., Batool, K., Walji, S., & Abbas, M. K. (2025) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2025.1557177 · Cited by 74 · see citing works

Altered medial temporal lobe responses during visuospatial encoding in healthy APOE*4 carriers

Borghesani, P. R., Johnson, L. C., Shelton, A. L., Peskind, E. R., Aylward, E., Schellenberg, G. D., & Cherrier, M. M. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.01.012 · Cited by 68 · see citing works

Role of Medium Chain Triglycerides (Axona ® ) in the Treatment of Mild to Moderate Alzheimer’s Disease

Sharma, A. K., Bemis, M., & Desilets, A. R. (2014) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317513518650 · Cited by 54 · see citing works

Apolipoprotein E4 mediates insulin resistance-associated cerebrovascular dysfunction and the post-prandial response

Johnson, L. A., Torres, E. R., Weber Boutros, S., Patel, E., Akinyeke, T., Alkayed, N. J., & Raber, J. (2019) · Journal of Cerebral Blood Flow &amp; Metabolism · doi:10.1177/0271678x17746186 · Cited by 56 · see citing works

Statistical Approaches to Functional Neuroimaging Data

Bowman, F. D., Guo, Y., & Derado, G. (2007) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2007.09.002 · Cited by 41 · see citing works

Imaging epigenetics in Alzheimer's disease.

Lista, S., Garaci, F., Toschi, N., & Hampel, H. (2013) · Current pharmaceutical design · doi:10.2174/13816128113199990370 · Cited by 37 · see citing works

Evaluation of Two Automated Methods for PET Region of Interest Analysis

Schain, M., Varnäs, K., Cselényi, Z., Halldin, C., Farde, L., & Varrone, A. (2014) · Neuroinformatics · doi:10.1007/s12021-014-9233-6 · Cited by 28 · see citing works

Emerging Therapeutic Promise of Ketogenic Diet to Attenuate Neuropathological Alterations in Alzheimer’s Disease

Uddin, M. S., Kabir, M. T., Tewari, D., Mamun, A. A., Barreto, G. E., BUNGAU, S. G., Bin-Jumah, M. N., Abdel‐Daim, M. M., & Ashraf, G. M. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02065-3 · Cited by 27 · see citing works

Arterial Input Function Derived from Pairwise Correlations Between PET-image Voxels

Schain, M., Benjaminsson, S., Varnäs, K., Forsberg, A., Halldin, C., Lansner, A., Farde, L., & Varrone, A. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.47 · Cited by 25 · see citing works

Subtle Gray Matter Changes in Temporo-Parietal Cortex Associated with Cardiovascular Risk Factors

Alves, T. C. T. F., Scazufca, M., Squarzoni, P., Duran, F., Tamashiro-Duran, J. H., Vallada, H., Andrei, A. M., Wajngarten, M., Menezes, P. R., & Busatto, G. F. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110827 · Cited by 23 · see citing works

Human gene therapy and imaging in neurological diseases

Jacobs, A. H., Winkler, A., Castro, M. G., & Lowenstein, P. R. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1960-3 · Cited by 23 · see citing works

Efficacy of Adjunctive Extra Virgin Coconut Oil Use in Moderate to Severe Alzheimer?s Disease

Gandotra, S., & Kour, J. (2014) · International Journal of School and Cognitive Psychology · doi:10.4172/2469-9837.1000108 · Cited by 18 · see citing works

New Perspectives for the Diagnosis of Alzheimers Disease

Urbanelli, L., Magini, A., Ciccarone, V. A., Trivelli, F., Polidoro, M., Tancini, B., & Emiliani, C. (2009) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488909789104839 · Cited by 17 · see citing works

Alzheimer's Disease: Fatty Acids We Eat may be Linked to a Specific Protection via Low-dose Aspirin.

Pomponi, M. F. L., Gambassi, G., Pomponi, M., & Masullo, C. (2010) · Europe PMC (PubMed Central) · Cited by 15 · see citing works

Cardiovascular risk in cognitively preserved elderlies is associated with glucose hypometabolism in the posterior cingulate cortex and precuneus regardless of brain atrophy and apolipoprotein gene variations

Tamashiro-Duran, J. H., Squarzoni, P., Duran, F., Curiati, P. K., Vallada, H., Buchpiguel, C. A., Lotufo, P. A., Wajngarten, M., Menezes, P. R., Scazufca, M., et al. (2012) · AGE · doi:10.1007/s11357-012-9413-y · Cited by 14 · see citing works

Decanoic Acid Rescues Differences in AMPA-Mediated Calcium Rises in Hippocampal CA1 Astrocytes and Neurons in the 5xFAD Mouse Model of Alzheimer’s Disease

Abghari, M., Vu, J. T. C. M., Eckberg, N., Aldana, B. I., & Kohlmeier, K. A. (2023) · Biomolecules · doi:10.3390/biom13101461 · Cited by 11 · see citing works

Alzheimer’s disease: More than amyloid

Chew, S. H., Tomic, M. M. (., & Cheung, A. (2010) · Clinical Hemorheology and Microcirculation · doi:10.3233/ch-2010-1356 · Cited by 11 · see citing works

Brain microvascular endothelial cell metabolism and its ties to barrier function

Weber, C. M., Moiz, B., & Clyne, A. M. (2024) · Vitamins and hormones · doi:10.1016/bs.vh.2024.05.002 · Cited by 6 · see citing works

fMRI in Psychiatric Disorders

Habecker, E. L., Daniels, M. A., & Renshaw, P. F. (2009) · Neuromethods · doi:10.1007/978-1-60327-919-2_21 · Cited by 5 · see citing works

Plasma p-tau217 in Alzheimer’s disease is a dynamic gauge of progression heterogeneity, not a baseline stratifier

Franco, R. (2025) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2025.1004118 · Cited by 2 · see citing works

Neurophysiologische Untersuchungsmethoden in der Psychiatrie

Pogarell, O. M., & Hegerl, U. (2015) · Springer eBooks · doi:10.1007/978-3-642-45028-0_28-1 · Cited by 2 · see citing works

Structural brain imaging in patients with cognitive impairment in the year 2015

Testa, C., Caroli, A., Roberto, V., & Frisoni, G. B. (2005) · Future Neurology · doi:10.2217/14796708.1.1.77 · Cited by 2 · see citing works

Neurophysiologische Untersuchungsmethoden

Pogarell, O. M., & Hegerl, U. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_25 · Cited by 2 · see citing works

Neurophysiologische Untersuchungsmethoden in der Psychiatrie

Pogarell, O. M., & Karch, S. (2017) · Springer Reference Medizin · doi:10.1007/978-3-642-45028-0_28-2 · Cited by 1 · see citing works

Mózgowy metabolizm glukozy i wybranych jej transporterów w chorobach neurodegeneracyjnych.

Białoń, N., Trzęsicki, M., Górka, M., Suszyńśki, K., & Górka, D. (2022) · Postępy Biochemii · doi:10.18388/pb.2021_463 · Cited by 1 · see citing works

Role of Artificial Intelligence (Random Forest) Based Advances Detection and Development Prediction Version of Alzheimer's Diseases

Joshi, P., Rautela, J., Gairola, N., Raj, A., Ghildiyal, P., & Suyal, J. (2023) · International Conference on Advanced Computing & Communication Technologies (ICACCTech) · doi:10.1109/icacctech61146.2023.00051 · Cited by 1 · see citing works

The ketogenic diet and healthy brain aging

Rogerson, G., & Preedy, V. R. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-817990-1.00049-4 · Cited by 1 · see citing works

Dementia

Lamar, M., Wortzel, H. S., Libon, D. J., Wambach, D. M., Price, C. C., & Kumar, A. A. (2012) · Wiley eBooks · doi:10.1002/9781119968900.ch4 · Cited by 1 · see citing works

Memory, genes, and brain imaging : relating the APOE gene to brain function and structure

Lind, J. (2007) · Figshare

Alterações metabólicas cerebrais associadas aos fatores de risco cardiovascular: um estudo de tomografia por emissão de pósitron (PET)

Tamashiro-Duran, J. H. (2011) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2011.tde-03012012-094605

From Normal to Pathological Ageing - The Spectrum of Mild Cognitive Impairment and Alzheimer’s Disease

Mielke, R., & Kessler, J. (2006) · European Neurological Review · doi:10.17925/enr.2006.00.02.74

The Effect of head punches on Some Physiological and Psychological Responses of Boxers

Salah, M., & Mohammed, A.-D. (2012)

fMRI in Psychiatric Disorders

Habecker, E. L., Daniels, M. A., Canu, E., Rocca, M. A., Filippi, M., & Renshaw, P. F. (2016) · Neuromethods · doi:10.1007/978-1-4939-5611-1_22

Cognition

Young, R. (2021) · Wiley eBooks · doi:10.1002/0471266949.bmc242.pub2

Imaging and CSF Studies in the Preclinical Diagnosis of Alzheimer's Disease

de Leon, M. J., Mosconi, L., Blennow, K., DeSanti, S., Zinkowski, R. P., Mehta, P. D., Praticò, D., Tsui, W., Louis, L. A. S., Sobanska, L., et al. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1379.012 · Cited by 198 · see citing works

MRI- and PET-Based Imaging Markers for the Diagnosis of Alzheimer’s Disease

Teipel, S. J., Sperling, R. A., Skudlarski, P., Jack, C. R., Hampel, H. J., Fellgiebel, A., & Herholz, K. (2012) · Advances in biological psychiatry · doi:10.1159/000335393 · Cited by 1 · see citing works

Neuroimaging and Early Diagnosis of Alzheimer Disease: A Look to the Future

Petrella, J. R., Coleman, R. E., & Doraiswamy, P. M. (2003) · Radiology · doi:10.1148/radiol.2262011600 · Cited by 427 · see citing works

Biomarkers for Early Detection of Alzheimer Pathology

Clark, C. M., Davatzikos, C. A., Borthakur, A., Newberg, A. B., Leight, S., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Neurosignals · doi:10.1159/000109754 · Cited by 94 · see citing works

Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer's disease

Villemagne, V. L., Rowe, C. C., Macfarlane, S., Novakovic, K. E., & Masters, C. L. (2005) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2004.03.011 · Cited by 50 · see citing works